Acceptability and perceived helpfulness of single session mindfulness and cognitive restructuring strategies in individuals with social anxiety disorder: A pilot study.

2019 ◽  
Vol 51 (2) ◽  
pp. 83-89
Author(s):  
Bethany Shikatani ◽  
Beverley K. Fredborg ◽  
Stephanie E. Cassin ◽  
Janice R. Kuo ◽  
Martin M. Antony
Keyword(s):  
Anxiety Disorder ◽  
Pilot Study ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Cognitive Restructuring ◽  
Single Session ◽  
Perceived Helpfulness

scholarly journals The Effects of Approach–Avoidance Modification on Social Anxiety Disorder: A Pilot Study

2013 ◽  
Vol 38 (2) ◽  
pp. 226-238 ◽  
Author(s):  
Anu Asnaani ◽  
Mike Rinck ◽  
Eni Becker ◽  
Stefan G. Hofmann
Keyword(s):  
Anxiety Disorder ◽  
Pilot Study ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Approach Avoidance

Citalopram for Social Anxiety Disorder: An Open-label Pilot Study in Refractory and Nonrefractory Patients

CNS Spectrums ◽  
2002 ◽  
Vol 7 (9) ◽  
pp. 655-657 ◽  
Author(s):  
Naomi M. Simon ◽  
Nicole B. Korbly ◽  
John J. Worthington ◽  
Gustavo Kinrys ◽  
Mark H. Pollack
Keyword(s):  
Anxiety Disorder ◽  
Pilot Study ◽  
Social Anxiety ◽  
Social Anxiety Disorder ◽  
Prior Treatment ◽  
Treatment Intervention ◽  
Treatment Trial ◽  
Open Label ◽  
Systematic Data ◽  
Open Label Trial

ABSTRACTThere is limited systematic data assessing alternate pharmacotherapy of social anxiety disorder in patients failing to tolerate or fully respond to initial treatment; no data specifically address the efficacy of citalopram in this scenario. We present a prospective open-label trial of citalopram in 10 patients with generalized social anxiety disorder, 6 of 10 of whom had not responded to or not tolerated a prior treatment intervention for the disorder. Citalopram, at a mean dose of 55 mg (SD+12.7 mg) was well tolerated, and patients improved significantly on all outcome measures. Results of this study suggest that citalopram may be a safe and effective treatment for generalized social anxiety disorder, including patients who have failed to tolerate or respond to a prior treatment trial.

Sign in / Sign up

Export Citation Format

Share Document